AAAAAA

   
Results: 1-22 |
Results: 22
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families
Authors: Verhoog, LC van den Ouweland, AMW Berns, E van Veghel-Plandsoen, MM van Staveren, IL Wagner, A Bartels, CCM Tilanus-Linthorst, MMA Devilee, P Seynaeve, C Halley, DJJ Niermeijer, MF Klijn, JGM Meijers-Heijboer, H
Citation: Lc. Verhoog et al., Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families, EUR J CANC, 37(16), 2001, pp. 2082-2090
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk
Authors: Brekelmans, CTM Seynaeve, C Bartels, CCM Tilanus-Linthorst, MMA Meijers-Heijboer, EJ Crepin, CMG van Geel, AN Menke, M Verhoog, LC van den Ouweland, A Obdeijn, IM Klijn, JGM
Citation: Ctm. Brekelmans et al., Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk, J CL ONCOL, 19(4), 2001, pp. 924-930
Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane
Authors: Smorenburg, CH Bontenbal, M Seynaeve, C van Zuylen, C de Heus, G Verweij, J de Wit, R
Citation: Ch. Smorenburg et al., Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane, BREAST CANC, 66(1), 2001, pp. 83-87
Untitled
Authors: Ansink, AC Burger, CW Seynaeve, C
Citation: Ac. Ansink et al., Untitled, GYNECOL ONC, 83(2), 2001, pp. 445-445
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
Authors: Meijers-Heijboer, H van Geel, B van Putten, WLJ Henzen-Logmans, SC Seynaeve, C Menke-Pluymers, MBE Bartels, CCM Verhoog, LC van den Ouweland, AMW Niermeijer, MF Brekelmans, CTM Klijn, JGM
Citation: H. Meijers-heijboer et al., Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation., N ENG J MED, 345(3), 2001, pp. 159-164
A comparative atomic force microscopy study on living skin fibroblasts andliver endothelial cells
Authors: Braet, F de Zanger, R Seynaeve, C Baekeland, M Wisse, E
Citation: F. Braet et al., A comparative atomic force microscopy study on living skin fibroblasts andliver endothelial cells, J ELEC MICR, 50(4), 2001, pp. 283-290
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study
Authors: Klijn, JGM Beex, LVAM Mauriac, L van Zijl, JA Veyret, C Wildiers, J Jassem, J Piccart, M Burghouts, J Becquart, D Seynaeve, C Mignolet, F Duchateau, L
Citation: Jgm. Klijn et al., Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study, J NAT CANC, 92(11), 2000, pp. 903-911
Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients
Authors: Smorenburg, CH Seynaeve, C Bontenbal, M Planting, A Sindermann, H Verweij, J
Citation: Ch. Smorenburg et al., Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients, ANTI-CANC D, 11(10), 2000, pp. 825-828
Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients
Authors: Verhoog, LC Berns, EMJJ Brekelmans, CTM Seynaeve, C Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients, J CL ONCOL, 18(21), 2000, pp. 119S-124S
Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Authors: Verweij, J Lee, SM Ruka, W Buesa, J Coleman, R van Hoessel, R Seynaeve, C di Paola, ED van Glabbeke, M Tonelli, D Judson, IR
Citation: J. Verweij et al., Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, J CL ONCOL, 18(10), 2000, pp. 2081-2086
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
Authors: Meijers-Heijboer, EJ Verhoog, LC Brekelmans, CTM Seynaeve, C Tilanus-Linthorst, MMA Wagner, A Dukel, L Devilee, P van den Ouweland, AMW van Geel, AN Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation, LANCET, 355(9220), 2000, pp. 2015-2020
Genetic testing and prophylactic surgery in familiar clusters of BRCA1 or BRCA2 mutation
Authors: Meijers-Heijboer, EJ Verhoog, LC Brekelmans, CTM Seynaeve, C Tilanus-Linthorst, MMA Wagner, A Dukel, L Devilee, P van den Ouweland, AMW van Geel, AN Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Genetic testing and prophylactic surgery in familiar clusters of BRCA1 or BRCA2 mutation, GYNAKOLOGE, 33(10), 2000, pp. 768-769
Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
Authors: Verhoog, LC Brekelmans, CTM Seynaeve, C Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer, BR J CANC, 83(3), 2000, pp. 384-386
The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting
Authors: Verweij, J Seynaeve, C
Citation: J. Verweij et C. Seynaeve, The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting, SEM RAD ONC, 9(4), 1999, pp. 352-359
Survival in hereditary breast cancer associated with germline mutations ofBRCA2
Authors: Verhoog, LC Brekelmans, CTM Seynaeve, C Dahmen, G van Geel, AN Bartels, CCM Tilanus-Linthorst, MMA Wagner, A Devilee, P Halley, DJJ van den Ouweland, AMW Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Survival in hereditary breast cancer associated with germline mutations ofBRCA2, J CL ONCOL, 17(11), 1999, pp. 3396-3402
Breast cancer screening in high-risk women
Authors: Brekelmans, CTM Bartels, CCM Crepin, E van Geel, AN Meijers-Heijboer, H Seynaeve, C Tilanus-Linthorst, MMA Verhoog, LC Wagner, A Klijn, JGM
Citation: Ctm. Brekelmans et al., Breast cancer screening in high-risk women, DIS MARKER, 15(1-3), 1999, pp. 34-36
Pit cells (hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway
Authors: Vermijlen, D Luo, DZ Robaye, B Seynaeve, C Baekeland, M Wisse, E
Citation: D. Vermijlen et al., Pit cells (hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway, HEPATOLOGY, 29(1), 1999, pp. 51-56
Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells
Authors: Luo, DZ Vermijlen, D Vanderkerken, K Kuppen, PJK Seynaeve, C Eddouks, M Baekeland, M Wisse, E
Citation: Dz. Luo et al., Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells, J HEPATOL, 31(1), 1999, pp. 110-116
High-dose chemotherapy in adult sarcomas: No standard yet
Authors: Seynaeve, C Verweij, J
Citation: C. Seynaeve et J. Verweij, High-dose chemotherapy in adult sarcomas: No standard yet, SEMIN ONCOL, 26(1), 1999, pp. 119-133
The 21-aminosteroid U-74389G enhances hepatic blood flow and preserves sinusoidal endothelial cell function and structure in endotoxin-shocked dogs
Authors: Spapen, H Zhang, HB Wisse, E Baekeland, M Seynaeve, C Eddouks, M Vincent, JL
Citation: H. Spapen et al., The 21-aminosteroid U-74389G enhances hepatic blood flow and preserves sinusoidal endothelial cell function and structure in endotoxin-shocked dogs, J SURG RES, 86(2), 1999, pp. 183-191
Participation of CD45 on pit cells and MHC class I on target cells in rat hepatic NK cell (pit cell)-mediated cytotoxicity against colon carcinoma cells
Authors: Luo, D Vermijlen, D Vanderkerken, K Kuppen, PJK Seynaeve, C Eddouks, M Wisse, E
Citation: D. Luo et al., Participation of CD45 on pit cells and MHC class I on target cells in rat hepatic NK cell (pit cell)-mediated cytotoxicity against colon carcinoma cells, CELLS OF THE HEPATIC SINUSOID, VOL 7, 1999, pp. 287-291
Pit cells of the rat induce apoptosis in colon carcinoma cells in vitro
Authors: Vermijlen, D Luo, D Robaye, B Seynaeve, C Baekeland, M Konstandoulaki, M Eddouks, M Wisse, E
Citation: D. Vermijlen et al., Pit cells of the rat induce apoptosis in colon carcinoma cells in vitro, CELLS OF THE HEPATIC SINUSOID, VOL 7, 1999, pp. 302-305
Risultati: 1-22 |